115 related articles for article (PubMed ID: 7550596)
1. A decrease in neural sialyltransferase activity in Alzheimer's disease.
Maguire TM; Breen KC
Dementia; 1995; 6(4):185-90. PubMed ID: 7550596
[TBL] [Abstract][Full Text] [Related]
2. Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease.
Cross AJ; Crow TJ; Perry EK; Perry RH; Blessed G; Tomlinson BE
Br Med J (Clin Res Ed); 1981 Jan; 282(6258):93-4. PubMed ID: 6779929
[TBL] [Abstract][Full Text] [Related]
3. Decreased activities of thiamine diphosphatase in frontal and temporal cortex in Alzheimer's disease.
Rao VL; Richardson JS; Butterworth RF
Brain Res; 1993 Dec; 631(2):334-6. PubMed ID: 8131063
[TBL] [Abstract][Full Text] [Related]
4. Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease.
Sorbi S; Piacentini S; Amaducci L
Gerontology; 1987; 33(3-4):197-202. PubMed ID: 3653702
[TBL] [Abstract][Full Text] [Related]
5. A decrease in serum sialyltransferase levels in Alzheimer's disease.
Maguire TM; Gillian AM; O'Mahony D; Coughlan CM; Dennihan A; Breen KC
Neurobiol Aging; 1994; 15(1):99-102. PubMed ID: 8159268
[TBL] [Abstract][Full Text] [Related]
6. Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease.
Bigl M; Brückner MK; Arendt T; Bigl V; Eschrich K
J Neural Transm (Vienna); 1999; 106(5-6):499-511. PubMed ID: 10443553
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of an extensive trans-tubular network continuous with the Golgi apparatus stack that may function in glycosylation.
Roth J; Taatjes DJ; Lucocq JM; Weinstein J; Paulson JC
Cell; 1985 Nov; 43(1):287-95. PubMed ID: 3000603
[TBL] [Abstract][Full Text] [Related]
8. Postnatal D2-CAM/N-CAM sialylation state is controlled by a developmentally regulated Golgi sialyltransferase.
Breen KC; Kelly PG; Regan CM
J Neurochem; 1987 May; 48(5):1486-93. PubMed ID: 3559563
[TBL] [Abstract][Full Text] [Related]
9. Regionally selective alterations in G protein subunit levels in the Alzheimer's disease brain.
O'Neill C; Wiehager B; Fowler CJ; Ravid R; Winblad B; Cowburn RF
Brain Res; 1994 Feb; 636(2):193-201. PubMed ID: 8012802
[TBL] [Abstract][Full Text] [Related]
10. Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease.
Leake A; Morris CM; Whateley J
Neurosci Lett; 2000 Sep; 291(3):201-3. PubMed ID: 10984641
[TBL] [Abstract][Full Text] [Related]
11. Assessment of activation of the plasma kallikrein-kinin system in frontal and temporal cortex in Alzheimer's disease and vascular dementia.
Ashby EL; Love S; Kehoe PG
Neurobiol Aging; 2012 Jul; 33(7):1345-55. PubMed ID: 21074291
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical Characterization of PSA-NCAM
Murray HC; Swanson MEV; Dieriks BV; Turner C; Faull RLM; Curtis MA
Neuroscience; 2018 Feb; 372():289-303. PubMed ID: 29429526
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease.
Barnes NM; Cheng CH; Costall B; Naylor RJ; Williams TJ; Wischik CM
Eur J Pharmacol; 1991 Aug; 200(2-3):289-92. PubMed ID: 1664329
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
[TBL] [Abstract][Full Text] [Related]
15. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype.
Allen SJ; MacGowan SH; Tyler S; Wilcock GK; Robertson AG; Holden PH; Smith SK; Dawbarn D
Neurosci Lett; 1997 Dec; 239(1):33-6. PubMed ID: 9547165
[TBL] [Abstract][Full Text] [Related]
16. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease.
Mutisya EM; Bowling AC; Beal MF
J Neurochem; 1994 Dec; 63(6):2179-84. PubMed ID: 7964738
[TBL] [Abstract][Full Text] [Related]
17. The trans-tubular network of the hepatocyte Golgi apparatus is part of the secretory pathway.
Taatjes DJ; Roth J
Eur J Cell Biol; 1986 Dec; 42(2):344-50. PubMed ID: 3028805
[TBL] [Abstract][Full Text] [Related]
18. Impaired proteasome function in Alzheimer's disease.
Keller JN; Hanni KB; Markesbery WR
J Neurochem; 2000 Jul; 75(1):436-9. PubMed ID: 10854289
[TBL] [Abstract][Full Text] [Related]
19. Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains.
Norris PJ; Faull RL; Emson PC
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):36-49. PubMed ID: 8883932
[TBL] [Abstract][Full Text] [Related]
20. The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
Wilcock GK; Esiri MM; Bowen DM; Smith CC
Neuropathol Appl Neurobiol; 1983; 9(3):175-9. PubMed ID: 6877514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
